In a previous report two forms of primary hyperglyceridemia1 were described, one caused by a failure to clear dietary fats at normal rates, the other induced by high-carbohydrate diets (1) . Levels of serum triglycerides can be lowered in the former case by diets low in fat or diets in which long-chain fats are replaced by mediumchain fats (2) . In carbohydrate-induced hyperglyceridemia, however, serum concentrations of triglycerides are reduced by substituting fat for carbohydrate in the diet.
Although future studies may develop a still more meaningful categorization of primary hyperlipemia, present experience (1, (3) (4) (5) (6) indicates that many patients with high serum triglyceride concentrations fall into one of the two groups described, and further, that carbohydrate-induced hyperglyceridemia is the more common abnormality. Eleven of twelve adequately studied cases of fat-induced hyperlipemia (1, 3, 7, 8) have shown very low levels of lipoprotein lipase activity in the plasma after iv injection of heparin, a finding that appears to explain the characteristically slow clearance of chylomicrons from the circulating blood. However, the basic defect in carbohydrate-induced lipemia, in which lipoprotein lipase activity is normal, remains unclear. That the serum triglycerides arise by lipogenesis from carbohydrate rather than by mobilization of adipose tissue fatty acids has been demonstrated (1) . Indeed, all mammalian organisms would be expected to convert a large proportion of dietary carbohydrate to fat when sugars are fed at high caloric levels, for ingested carbohydrate will ex-* Submitted for publication August 1, 1963 ; accepted November 14, 1963. Supported in part by U. S. Public Health Service grant HE-06222-02, National Heart Institute.
1 In this report we shall not be concerned with the secondary hyperlipemias seen in nephrosis, starvation, hypothyroidism, glycogen storage disease, hemolytic anemia, or multiple myeloma.
ceed energy needs at certain times of the day, and storage in the form of glycogen is limited. Nevertheless, there remains the intriguing question of why some individuals have more than normal amounts of triglycerides in the plasma under such circumstances. That normal men develop hyperglyceridemia on high-carbohydrate diets has been demonstrated by Antonis and Bersohn (9) , but the effect they described was small and transient, lasting only several months. Since certain populations that live habitually on high-carbohydrate, low-fat diets do not manifest hyperglyceridemia, normal men apparently adapt to a high-carbohydrate intake, and persistent carbohydrate-induced hyperglyceridemia seems to represent a metabolic abnormality.
Three observations suggest that patients with carbohydrate-induced hyperglyceridemia might have defective secretion or utilization of insulin: 1) in normal subjects carbohydrate ingestion is a major stimulus to insulin secretion (10, 11), 2) diabetics have lower concentrations of serum triglycerides when optimally managed with insulin than when untreated, even in the absence of acidosis (12, 13) , and 3) mild diabetes develops as a sequel to hyperlipemia (14) . 'These considerations led to the present study, which describes two parameters of carbohydrate metabolism in patients with the two forms of hyperglyceridemia. The findings indicate that an abnormality of carbohydrate metabolism exists in carbohydrate-induced hyperglyceridemia.
Methods
Clinical data (Table I ). This report is based on studies of 23 patients: 10 carbohydrate-induced and 3 fat-induced hyperglyceridemia, 3 maturity-onset diabetes, and 7 controls with no evidence of diabetes or hyperglyceridemia. A comparison of tolbutamide responsiveness in the two forms of hyperglyceridemia was the primary focus of this study. In addition, small numbers of diabetic and of nondiabetic, nonhyperlipemic pa- Three additional patients, referred for study of hyperlipemia, were found to have maturity-onset diabetes. None had a family history of diabetes. Two were asymptomatic but had abnormal oral glucose tolerance tests. The third (H.K.) had a history of acidosis, increased concentrations of blood sugar when fasting, an abnormal oral glucose tolerance test, and attacks of acute abdominal crises. Her glycosuria was significantly reduced with oral tolbutamide. All three had coronary insufficiency or claudication.
Seven subjects are called "normal controls" for the purposes of this study, because their serum triglyceride levels and responsiveness to tolbutamide were within normal limits. However, they were not all free of disease. One had coronary insufficiency, and another had peripheral vascular disease, but none of the 7 showed clinical or laboratory evidence of hyperlipemia, diabetes, skin xanthomatosis, or abdominal symptoms. One had a family history of diabetes. Two had hypercholesteremia without hyperglyceridemia. Three of these 7 patients were fed high-and low-carbohydrate diets on the metabolic ward and failed to show significant changes in serum triglyceride levels in studies lasting several months.
The diets of the patients and controls, as well as relevant clinical data, are summarized in Table I . In addition to ad libitum diet periods, various controlled feeding regimens were utilized. At those times, feedings were composed solely of orally administered liquid formulas supplemented with minerals and vitamins (16) . Protein, fat, and carbohydrate intakes (P: F: C) were varied as follows: Diet A, P:F:C=15:0:85; Diet B, P:F:C=15:40:45; Diet C, P:F:C=15:70:15, all as percentages of total calories. Carbohydrate intakes exceeded 200 g per day on Diets A and B and during ad libitum feedings. Note that on all formula regimens the dietary carbohydrate consisted solely of glucose. Various dietary fats (corn oil, lard, and three triglycerides synthesized from linoleic acid, palmitic and oleic acids, and octanoic and decanoic acids) were utilized, with effects on serum triglyceride concentrations that have been described elsewhere (1, 2, 16) . Substitution of one fat for another had no apparent effect on the indexes of carbohydrate metabolism currently under study. All patients were ambulatory and were maintained at constant weights by appropriate adjustment of caloric intake. Tolbutamide studies were carried out only after serum triglyceride levels had stabilized on a given dietary regimen.
Laboratory procedure. Serum lipid concentrations were determined as previously described (16), and lipoprotein lipase activity was assayed. 2 Blood glucose levels were determined by the glucostat enzymatic method, using glucose oxidase.3 Oral glucose tolerance tests were performed with a 100-g loading dose;
venous bleedings were carried out periodically for 3 to 5 hours. Tolerance tests were considered normal when fasting levels were lower than 100, 1-hour levels lower than 160, and 2-hour levels lower than 110 mg per 100 ml whole blood. After glucagon stimulation (2 mg intravenously) blood glucose levels were followed at 10-minute intervals for 60 minutes. Results were compared to those of Kirtley, Waife, Helmer, and Peck (17) .
Responses to tolbutamide4 (1 g in 20 ml distilled water administered intravenously over a 2-minute period to adults, 25 mg per kg of body weight to children) were assayed in terms of changes in blood sugar concentration as described by Unger and Madison (18) , and in insulin-like activity (ILA) by a modification of the rat epididymal fat pad assay (19) . Blood samples were drawn at 20, 30, 60, and 90 minutes. The samples for sugar determinations were collected in tubes containing heparin and fluoride. Sera were frozen until assayed for ILA.
Assays of ILA were carried out after adjusting serum glucose contents to 250 mg per 100 ml. Insulin standards 5 were run with each analysis at levels of 476 and 38 ,U per ml medium. The conversion of glucose-6-C14 to labeled triglyceride by rat epididymal fat pad tissue was taken as a function of ILA. (In the pres--ence of insulin more than 80% of the radioactivity incorporated into triglyceride was found in the fatty acid moiety.) After the fat pad segments were washed three times in water to remove adhering labeled glucose, extractions were made in Dole's solvent system (20) jection of tolbutamide in relation to the various diets are shown in Table II . No consistent effects of diet could be detected when interdietary comparisons were made in individual patients or in disease groups, although responses were tested during the feeding of two or more diets in 15 patients. As a general rule increased carbohydrate intakes did not improve the responsiveness to tolbutamide in any of the four patient groups. In fact, in 3 patients with carbohydrate-induced hyperglyceridemia (T.M., E.K., and R.K.) a somewhat greater decrease was seen at 20 minutes on Diet B than on ad libitum or Diet A. Nevertheless, their responses on Diet B were still smaller in degree than those of all normal subjects on any diet.
For graphic presentation in Figure 1 , the raw data were normalized by relating them to Responses to tolbutamide at 20 and 30 minutes were significantly different in the normal and carbohydrate-induced groups (p < 0.01 by the t test on percentage differences from fasting levels).
Fasting blood sugar levels (Table II) were not significantly different in the two forms of hyperglyceridemia and in the normal group but were slightly elevated in the 3 diabetics.
Responses of serunm ILA to tolbutamide (Table   III) . Twenty-eight ILA tests were carried out in 15 subjects (4 normal, 3 diabetes, 2 fat-induced and 6 carbohydrate-induced hyperglyceridemia) on four diets. No systematic effect of diet could be detected when interdietary comparisons were made in individual patients or in disease groups. Variations in ILA levels beyond those ascribable to methodologic error were noted in 3 of 11 patients tested at different times on various diets (J.S., C.M., and R.W.) ; these were variations in degree but not in pattern of response. Since these differences were not consistently related to amounts of carbohydrate and fat in the diet, multiple tests in individual patients on various diets were averaged, and the averages in each group were averaged for comparison in Figure 2 . Values are expressed as microunits of ILA per ml of serum above fasting levels. Figure 2 (upper) shows the mean increase in ILA provoked by iv infusion of tolbutamide in 4 normal and 3 diabetic subjects. The normal group displayed a more rapid response with peak values at 20 or 30 minutes and a rapid decrease to fasting levels at 60 minutes. Diabetic subjects showed elevated values at 60 minutes, which did not returrn toward fasting levels until 90 minutes. (Table II) was abnormal at 60 minutes and resembled those of the 9 other patients with this form of hyperglyceridemia. In general, then, ILA and blood sugar responses to tolbutamide were inversely related. Patients with decreased tolbutamide responsiveness as measured by sluggish decreases in blood sugar concentration had prolonged increases in ILA (diabetics and carbohydrate-induced hyperglyceridemia), whereas those who had a prompt decrease in blood sugar after tolbutamide also had prompt increases and decreases in ILA (normiial subjects and fat-induced lipemia).
Discussion
The data presented indicate that patients with carbohydrate-induced hyperglyceridemia have abnormal responses to tolbutamide resembling those seen in diabetes suspects and in mild diabetes. Unger and Madison (18) report a delayed and prolonged fall in blood sugar after tolbutamide administration in maturity-onset diabetics and in mild diabetics with normal blood sugar concentrations when fasting. Abnormal responses were found also in diabetes suspects (children of two diabetic parents and mothers of large stillborn babies) by Jackson and Keller (21). Yalow, Black, Villazon, and Berson (11) described a prolonged slow rise in serum insulin levels in maturity-onset diabetics after acute tolbutamide stimulation or glucose ingestion. Finally, Beigelman and Tranquada (22) found higher levels of fasting ILA in the blood of diabetes suspects than in normals. In the present study we have found abnormal responses in 9 of 10 patients with carbohydrate-induced hyperglyceridemia but in none of three patients with fat-induced hyperlipemia. Apparently carbohydrate-induced hyperglyceridemia may represent an abnormal pancreatic response to tolbutamide stimulation or inefficient peripheral utilization of the insulin released or release of an inactive or bound form of insulin -alternatives currently debated in the pathogenesis of diabetes (11, 23) .
A relationship between diabetes and hyperlipemia has been noted repeatedly in the last five decades. Indeed, Bradley, Eccles, and Freelender (14) noted that hyperlipemia may be an early manifestation of diabetes mellitus. In 1955, Adlersberg and Wang (24) (26) described the phenomenon of carbohydrate-induced hyperglyceridemia in 5 patients with diabetes mellitus.
It has not been determined whether the hyperglyceridemia induced by dietary carbohydrate represents increased synthesis, decreased utilization, "trapping" in the plasma, or a combination of these factors. To this end, Farquhar, Reaven, Gross, and Wagner (27) studied triglyceride kinetics in the D < 1.006 fraction of plasma in 2 patients with carbohydrate-induced hyperglyceridemia after their plasma glyceride concentrations had been stabilized at two levels by feeding highand low-carbohydrate diets, respectively. These investigators concluded that hepatic triglyceride synthesis is increased and that net removal of the particulate triglyceride is insufficient to prevent expansion of pool size.
The postulated imbalance between synthesis and utilization that accounts for the accumulation of triglycerides in the plasma presumably occurs during the transitional weeks immediately after the replacement of fat by carbohydrate calories. At this time the rate of production temporarily exceeds the rate of peripheral utilization. Soon, however, this imbalance is corrected, since eventually each patient's triglyceride concentration stabilizes at a new (but higher) level. During this new steady state, when on logical grounds the stimulus to lipogenesis would seem to be maximal, there must also be a greater net utilization (or clearance) of newly synthesized triglycerides. In normal subjects, reasoning from Antonis and Bersohn's results (9) , clearance finally exceeds production, and serum triglyceride levels return to normal, for they found a rise, then a plateau, and finally a fall in serum triglyceride over a 4-to 9-month period. We have noted the same sequence of events in several patients with the complete cycle lasting only 1 to 4 weeks. Why, then, do certain patients maintain increased concentrations of triglycerides in the plasma for many months, perhaps indefinitely?
The rise in plasma glycerides on high-carbohydrate diets may be caused by a partial defect in peripheral clearance of triglyceride-rich 8-lipoprotein particles. Indeed, we (28) and Bierman (29) The role of the liver in the development of carbohydrate-induced hyperglyceridemia also remains to be clarified, as well as the effect of insulin on the production of triglycerides by the liver. In one of our patients (T.M.) with carbohydrateinduced hyperglyceridemia, who was each day for 2 weeks given sufficient insulin by injection to produce sylmiptoms of hypoglycemia, there was no effect on serum triglyceride concentrations. After oral tolbutamide administration, however, a marked decrease in serum triglycerides was noted. As these preliminary results are extended, comparing the effects of endogenously secreted insulin (stimulated by tolbutamide) with exogenous insulin will be especially significant, since in the former case the liver is exposed first to the outpouring of insulin from the pancreas, whereas injected insulin may have its primary effect peripherally. Shipp and Munroe (32) noted an interesting fall in triglyceride levels in patients with mild diabetes treated with oral sulfonylurea. Summary 1. In ten patients with carbohydrate-induced hyperglyceridemia the response to a single intravenous dose of tolbutamide was measured by following changes in the concentration of blood sugar and serum insulin-like activity. The decrease in blood sugar was smaller in degree and the rebound was delayed, when compared to controls and three patients with fat-induced hyperlipemia. Levels of insulin-like activity rose more slowly than normally, a response previously noted in maturity-onset diabetes.
2. This evidence suggests that carbohydrateinduced hyperglyceridemia is in some manner allied to the prediabetic state in maturity-onset diabetes. We propose that the normal rate of clearance of plasma triglycerides may be determined in part by the action of insulin on peripheral tissues.
